Selected article for: "AST aspartate aminotransferase and WBC count"

Author: He, Chaobin; Wang, Jun; Sun, Shuxin; Zhang, Yu; Li, Shengping
Title: Immunomodulatory Effect after Irreversible Electroporation in Patients with Locally Advanced Pancreatic Cancer
  • Document date: 2019_5_12
  • ID: 1pbzbydu_6
    Snippet: . . Clinical Data Collection. The following clinical and radiological data were retrieved from medical record archived at Sun Yat-sen University Cancer Center, including age, gender, tumor size, tumor grade, tumor site, white blood cell (WBC) count, platelet (PLT) count, serum levels of alanine transaminase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), glutamyl transpeptidase (GGT), albumin (ALB), total bilirubin (TBIL), in.....
    Document: . . Clinical Data Collection. The following clinical and radiological data were retrieved from medical record archived at Sun Yat-sen University Cancer Center, including age, gender, tumor size, tumor grade, tumor site, white blood cell (WBC) count, platelet (PLT) count, serum levels of alanine transaminase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), glutamyl transpeptidase (GGT), albumin (ALB), total bilirubin (TBIL), indirect bilirubin (IBIL), Creactive protein (CRP), carcinoembryonic antigen (CEA), and carbohydrate antigen 19-9 (CA19-9). The inflammationbased indexes, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), prognostic index (PI), and modified Glasgow Prognostic Score (mGPS), were also entered into this study. The thresholds for the clinical or radiological variables were used as the cutoff values. With the cutoff value of 1.47 and 165.29, NLR and PLR were associated with the optimal Youden indexes for OS and progression-free survival (PFS) prediction, respectively. The defined score of other inflammation-based indexes, such as PI and mGPS, had been described in previous studies [19] .

    Search related documents:
    Co phrase search for related documents
    • alanine transaminase and ALP alkaline phosphatase: 1, 2, 3, 4, 5, 6
    • alanine transaminase and ALT alanine transaminase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • alanine transaminase and ALT alanine transaminase serum level: 1
    • alanine transaminase and aspartate aminotransferase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • alanine transaminase and AST aspartate aminotransferase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • alanine transaminase and blood cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • alanine transaminase and lymphocyte neutrophil: 1, 2, 3, 4, 5, 6
    • alanine transaminase and lymphocyte neutrophil ratio: 1, 2, 3, 4
    • alanine transaminase and lymphocyte platelet: 1, 2, 3, 4, 5
    • alanine transaminase and lymphocyte platelet ratio: 1, 2
    • alanine transaminase and medical record: 1, 2
    • alkaline phosphatase and blood cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • alkaline phosphatase and creactive protein: 1
    • alkaline phosphatase and cutoff value: 1, 2, 3
    • alkaline phosphatase and lymphocyte neutrophil: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • alkaline phosphatase and lymphocyte neutrophil ratio: 1, 2, 3, 4, 5
    • alkaline phosphatase and lymphocyte platelet: 1, 2, 3, 4
    • alkaline phosphatase and lymphocyte platelet ratio: 1, 2, 3
    • alkaline phosphatase and medical record: 1, 2, 3